Australia Patent: Novartis, The Trustees of the University of Pennsylvania File Application for 'BCMA-targeting chimeric antigen receptor, CD19-targeting chimeric antigen receptor, and combination therapies'

Press/Media

Period29 May 2020

Media coverage

1

Media coverage

  • TitleAustralia Patent: Novartis, The Trustees of the University of Pennsylvania File Application for 'BCMA-targeting chimeric antigen receptor, CD19-targeting chimeric antigen receptor, and combination therapies'
    Media name/outletAustralian Government News (Ht Media)
    Country/TerritoryAustralia
    Date29/05/20
    PersonsDavid Cohen